Objective-During pregnancy, fetal trophoblast disrupt endothelial cell and vascular smooth muscle cell (VSMC) interactions in spiral arteries of the maternal decidua to enable increased nutritional and oxygen delivery to the fetus. Little is known regarding this transformation because of difficulties of studying human pregnancy in vivo. This study investigated how trophoblast-secreted factors affect the interactions of vascular cells and the differentiation status of VSMC during spiral arteries remodeling using 3-dimensional vascular spheroid coculture. Methods and Results-Endothelial cell and VSMC were cocultured in hanging droplets to form spheroids representing an inverted vessel lumen. Control or conditioned media from an extravillous trophoblast (EVT) cell line was incubated with vascular spheroids for 24 hours. Spheroid RNA was then analyzed by Illumina Sentrix BeadChip array. Spheroids incubated with EVT conditioned medium showed significant up/downregulation of 101 genes (>1.5-fold; P<0.05), including an upregulation of C-X-C motif chemokine 10 (IP-10). C-X-C motif chemokine 10 expression was confirmed by qualitative real-time PCR and Western blot analysis of spheroids, and immunohistochemistry of first trimester decidua and ex vivo dissected nonplacental bed spiral arteries. EVT conditioned medium reduced VSMC expression of differentiation markers, and both EVT conditioned medium and C-X-C motif chemokine 10 increased motility of VSMC indicating dedifferentiation of VSMC. 
D
uring the first trimester of pregnancy, spiral arteries (SA) within the maternal uterus (decidua and myometrium) are remodeled from small diameter vessels with a low flow at high resistance, to those with a large diameter and high flow at low resistance. This transformation results in vessels that are not responsive to vasoconstrictors and provide increased blood flow to the fetus at a reduced pressure. Complete physiological remodeling of the SA is achieved only in the presence of fetal extravillous trophoblast (EVT). 1 EVT are specialized cells that migrate both into the decidual stroma and retrograde to flow in the lumen of SA, where they are termed endovascular trophoblast. 2 Endovascular trophoblast disrupt the interactions of the endothelial cells (EC) and vascular smooth muscle cells (VSMC) making up the SA, and eventually mediate the loss of these cells through mechanisms thought to involve apoptosis and dedifferentiation. 3 Endovascular trophoblast then replace the cells they have displaced, and adopt a more endotheliallike phenotype, 4 before reendothelialization occurs. Defects in this unique remodeling process have been associated with the onset of pregnancy disorders, including preeclampsia, intrauterine growth restriction, and preterm labor. Although the symptoms of these disorders commonly present later in pregnancy, inadequate SA remodeling is proposed to occur during the first trimester. 5 Relatively little is known regarding the mechanisms of normal SA remodeling because of the difficulties of studying early human pregnancy. Animal models are limited because of the lack of deep trophoblast invasion and SA transformation in other species. 6 Therefore, there is a need to model these multicellular interactions in vitro. Previous models include the use of monolayer cocultures, 7 explant cultures, 8 and endothelial capillary tubes on Matrigel. 9 These have revealed the secretion of a number of factors by endovascular trophoblast which impact on the physiological changes that occur in SA remodeling, including the secretion of proteases to degrade the extracellular matrix and disrupt cellular interactions, 10 and chemokines including interleukin (IL)-8, MCP-1, 11 and IL-6. 12 Trophoblast also induce reduced expression and disruption of EC adhesion molecules, such as E-cadherin, 13 and apoptosis of vascular cells. 14, 15 The use of 3-dimensional (3D) spheroid cell culture models may overcome some limitations of both monolayer cells and ex vivo explants in studying the initial stages of human placentation, as cells grown in 3D cultures retain a phenotype more similar to in vivo than in monolayer. 18 Vascular spheroids show some of the phenotypic properties of vessels, such as differentiation of EC as demonstrated by a downregulation of platelet-derived growth factor expression, CD34 expression, and a reduction in apoptosis. 19 A similarity to the structure of the vessel wall is also retained, with a monolayer of EC over a core of VSMC, however limitations are presented by the lack of connective tissue and shear stress present in a vessel. In this study, we used this 3D multicellular model to investigate changes in gene expression within the vasculature in response to trophoblast secreted factors using a genomewide microarray. Expression of C-X-C motif chemokine 10 (CXCL10; previously known as IP-10), a protein found to be upregulated in the array, has been reported in both EC and VSMC in response to proinflammatory stimuli, 20, 21 as well as some uterine EC in vivo.
22 CXCL10 has also previously been implicated in vessel destabilization, and therefore we investigated its role in SA remodeling and found that IFN-γ may be involved in the induction of CXCL10 in SA, and that EVT conditioned medium (CM) and CXCL10 contribute toward VSMC dedifferentiation and motility, key steps in the remodeling process.
Materials and Methods
Expanded methods are available in the online-only Data Supplement.
Cell Culture
The human vascular smooth muscle cell line SGHVSMC-9 (VSMC), human endothelial cell line SGHEC-7 (EC), and human EVT cell line SGHPL-4 were maintained, as previously described. 15, 23, 24 Generation of EVT CM SGHPL-4 cells were grown in 3D culture, as previously described, 24 and CM collected after 24 hours, as described in the Methods in the online-only Data Supplement.
Spheroid Generation
To generate spheroids, a hanging drop VSMC/EC coculture (750 cells each) method was used. 25, 26 Microarray Analysis RNA isolation, microarray analysis, and SYBR green quantitative real-time PCR was carried out, as described in the Methods in the online-only Data Supplement.
Western Blot Analysis
Spheroids (n=64) and monolayer VSMC were lysed in 50 µL RIPA buffer and Western blot analysis was carried out by standard procedure using rabbit anti-CXCL10, mouse antiα-smooth muscle actin, or rabbit anticalponin.
Ex Vivo Vessel Explant Model
Informed consent was obtained and ethical committee approval was in place for all studies. Decidual/myometrial biopsies (n=3) were obtained from nonplacental bed areas from pregnant women undergoing elective Caesarean section at term for reasons such as breech presentation. SA were dissected, as previously described. 8 Vessels were incubated with EVT CM for 24 hours, when arteries were cryosectioned for immunohistochemical staining.
Immunohistochemistry
All immunohistochemistry was carried out by standard procedures described in the online-only Data Supplement.
Microscopy
Confocal and time-lapse microscopy was carried out, as described in the online-only Data Supplement. 
Statistical Analysis

Results
Vascular Spheroids Form a Monolayer of EC Surrounding a Core of VSMC
To investigate the effect of trophoblast on the interaction of EC and VSMC in the remodeling SA, we used coculture vascular spheroids. To confirm that the orientation of EC and VSMC modeled a vessel, EC and VSMC were fluorescently labeled for confocal imaging. After 24 hours, the EC orientated to the exterior of the spheroid in a monolayer, as previously described ( Figure 1A) , 19 whereas the VSMC formed an internal core ( Figure 1B ). This culture system reestablished the orientation and cellular interactions between the EC monolayer and the underlying VSMC seen in the intact vessel in vivo ( Figure 1C) , and therefore was used to model the effects of endovascular trophoblast within the lumen of SA.
Genes Were Significantly Altered by Trophoblast CM
To analyze changes in gene expression in the vasculature induced by trophoblast-secreted factors, trophoblast CM generated from the EVT cell line SGHPL-4 grown in 3D was added to vascular spheroids and incubated for 24 hours. The resulting cRNA was hybridized to Illumina Sentrix BeadChip Array and data analyzed, as described in the Methods in the online-only Data Supplement. The comparison revealed 101 genes that were significantly altered >1.5-fold in CM-treated vascular spheroids as compared with control (C)-treated vascular spheroids (P<0.05; Table I in the online-only Data Supplement). Of these, 9 were downregulated and 92 were upregulated. A total of 10 genes showed a significant upregulation of over >2-fold (P<0.05; Table) . These genes were members of diverse families, which included cytokines, chemokines, and growth factors and included of particular interest chemokine (C-X-C motif) ligand 10 (CXCL10), chemokine e95 (C-C motif) ligand 20, stanniocalcin-1, IL-6, CD93, IL-11, platelet-derived growth factor, and placental growth factor. The full list was further analyzed by gene ontology analysis, and this revealed 36 significant biological processes (P<0.05) each containing between 2 and 54 genes (listed in full in Table II in the online-only Data Supplement). Of interest were ontologies relating to both cell proliferation and negative proliferation, response to wounding, various ontologies relating to signaling (including signal transduction, cell communication, cell-cell signaling), inflammatory response, and cell migration as well as some vascular processes (including angiogenesis, blood vessel development, and vascular development).
Microarray Verification
To verify the results of the array, quantitative real-time PCR was performed for the transcripts of CXCL10 (Figure 2A ), stanniocalcin-1 ( Figure 2B ), and placental growth factor ( Figure 2C ) using independently isolated RNA samples to those used for array analysis. This analysis confirmed a statistically significant increase in mRNA expression in CM-treated vascular spheroids of CXCL10 (7.9-fold, P<0.05; Figure 2A ), stanniocalcin-1 (2.3-fold, P<0.05; Figure 2B ), and placental growth factor (3.4-fold, P<0.05; Figure 2C ), as compared with control-treated spheroids. A time course over 48 hours was carried out to examine CXCL10 mRNA expression, which was found to peak at 24 hours ( Figure I in the online-only Data Supplement).
CXCL10 Protein Is Expressed by Vascular Spheroids in Response to Trophoblast CM
The expression of CXCL10 was chosen for further investigation, as it has previously been implicated in vessel destabilization in other vascular beds, however, mostly relating to its effects on EC. 27, 28 To further confirm the upregulation of CXCL10 by EVT CM in vascular spheroids, Western blot analysis was performed. Spheroids were formed of EC alone, VSMC alone, and in coculture. After 24 hours treatment, there was a small increase in CXCL10 protein expression when EC or VSMC were cultured alone, although this did not reach statistical significance. When EC and VSMC were cocultured in spheroids, there was a significant increase in CXCL10 expression of 3.7-fold in EC/VSMC spheroids treated with CM as compared with control (P<0.05; Figure  3A ). The fold increase in CXCL10 protein expression in EC/ VSMC spheroids was greater than the additive effect of the cell types cultured separately.
CXCL10 protein expression was also investigated by immunocytochemistry in vascular spheroids treated with control media or EVT CM. Cells positive for CXCL10 expression could be identified in sections of spheroids treated with control media ( Figure 3B ), however increased CXCL10 immunoreactivity was observed in vascular spheroids treated with EVT CM ( Figure 3C ). This appeared primarily to be present in the VSMC core; however, it could also be identified in the EC.
CXCL10 Expression in Ex Vivo SA and First Trimester Decidua
To confirm the expression of CXCL10 in a physiological setting, CXCL10 protein was examined by immunohistochemistry of serial sections of first trimester decidua. CXCL10 immunoreactivity was found widely throughout the stroma in all decidual sections examined (n=5; Figure 4A , and magnification Figure 4C ). We could colocalize CXCL10 expression with α-smooth muscle actin expression, indicating CXCL10 expression by VSMC ( Figure 4C and 4D, marked by arrowheads). Interestingly, cells expressing both smooth muscle actin and CXCL10 were also found a small distance away from the lumen of the artery. This was at a time when trophoblasts were present in the decidua (CK7 immunohistochemistry, B). CXCR3 expression was also examined in the decidua, and was also found to be localized to α-smooth muscle actin expression at a time when trophoblasts were present in the decidua ( Figure II in the online-only Data Supplement).
The role of EVT CM in inducing expression of CXCL10 was then examined in SA isolated from biopsies of nonplacental bed decidua/myometrium. SA were dissected and incubated with EVT CM for 24 hours. CXCL10 protein expression was examined by immunohistochemistry ( Figure 4) . Expression of CXCL10 (green channel) in the EC (red channel, identified by VWF immunostaining) and VSMC component (merge) was identified in arteries treated with EVT CM (Figure 4E-4G ).
CXCL10 Expression Is Partly Induced by IFN-γ
IFN-γ is a well-known stimulant of CXCL10, and recombinant IFN-γ can induce CXCL10 expression in vascular spheroids ( Figure 5A ). Previous studies have shown that EVT secrete IFN-γ. 29 We next examined whether IFN-γ in EVT CM was responsible for the induction of CXCL10 expression in the vascular spheroids. When IFN-γ was removed from EVT CM (using an IFN-γ-blocking antibody), before incubation with EC/VSMC spheroids for 24 hours, CXCL10 expression was reduced by an average of 4.5-fold as compared with CM incubated with control mouse IgG (P<0.05; Figure 5B ).
Effect of CXCL10 and EVT CM on VSMC
CXCL10 has been previously shown to alter functional dedifferentiation markers of VSMC, including motility. 30 During SA remodeling, this process may play a key role. Therefore, to determine a potential effect on SA of CXCL10 production, recombinant CXCL10 or EVT CM was added to cultures of VSMC for a period of 24 or 72 hours. The differentiation markers α-smooth muscle actin and calponin, motility and proliferation of VSMC were assessed after 72 hours. EVT CM significantly decreased the expression of α-smooth muscle actin ( Figure 6A ) and calponin ( Figure 6B ), indicating a switch to a noncontractile, dedifferentiated phenotype. Recombinant CXCL10 induced a small decrease in expression of these markers that did not reach statistical significance. Motility of VSMC was significantly and dose-dependently 
Discussion
Interactions between EC and VSMC are crucial to the stability of a vessel, and physical contact between these cells contributes to the phenotype and differentiation status of both cell types. 19 During decidual SA remodeling in the first trimester of pregnancy, this communication is disrupted and the structural integrity of the vessel is altered. This process is poorly understood because of the difficulties of accessing human implantation sites at this time and the lack of appropriate animal models. 6 However, understanding the role of fetal trophoblast in the disruption of the stable interactions between cells in the vessel wall of SA is crucial to our understanding of pathologies associated with inadequate vascular remodeling. This study aimed to examine the effect of trophoblast on EC and VSMC interactions using a vascular spheroid 3D coculture model. We determined that trophoblast induce a number of gene expression changes in the vasculature, including an upregulation of CXCL10, a protein not previously associated with SA remodeling. We examined the expression of CXCL10 in an ex vivo SA model and in first trimester decidual tissue, where it could be localized to α-smooth muscle actin positive cells. Finally, we demonstrated that trophoblast-secreted factors induced dedifferentiation and increased cellular motility of VSMC, a key process in decidual SA remodeling, and that this was, in part, because of CXCL10.
Gene profiling established 101 differentially expressed genes between vascular spheroids cultured with trophoblast CM and control medium. Gene ontology analysis identified that the genes most significantly altered were associated with vascular development. These included the cytokine chemokine (C-C motif) ligand 20 and the protease MMP-10, both of which have been associated with pathological vascular remodeling. 27 ,28 MMP-10 degrades collagen type IV and laminin which allows migration of both EC and VSMC. It is capable of stimulating EC motility and tube formation in a mouse angiogenesis plug assay, 31 and activation of MMP-1, and causes EC network regression by degradation of collagen.
32 Also upregulated by trophoblast-secreted factors were the cytokines IL-11 and IL-6, both members of the IL-6-type cytokine family. 33 and is downregulated in VSMC by cell-cell contact with trophoblast, yet can also be upregulated by the secreted factor TNF-α. 12 IL-6 is a proinflammatory cytokine and may affect EVT invasion and cytokine expression. 34 The related cytokine IL-11 is associated with implantation and is localized to first trimester decidual EC and VSMC, and although its role in these vessels is unknown, 35 it has been shown to inhibit VSMC proliferation, 36 and as such these 2 related cytokines have the potential for multiple effects in SA remodeling. Similarly, placental growth factor has been associated with apoptosis in vessel remodeling 37 and with the regulation of VEGF-dependent remodeling. 38 The expression of platelet-derived growth factor-BB that is known to stimulate the dedifferentiation of VSMC 39 was increased in response to trophoblast-secreted factors, as were 2 transcription factors, KLF-4 and c-myc, which are implicated in the mediation of this effect. 40 Therefore, these selected genes, and several others identified by this array, are useful targets that may contribute to the vessel remodeling process by their expression in EC and VSMC in SA.
IL-6 is expressed in myometrial arteries
Expression of the chemokine CXCL10 (previously known as IP-10) was found to be significantly upregulated in vascular spheroids and first trimester SA explants after treatment with EVT CM. It was also expressed by VSMC in the proximity of first trimester SA. However, to our knowledge, this is the first report implicating trophoblast-induced changes in CXCL10 in the physiological remodeling of maternal SA. CXCL10 modulates growth, chemotaxis, and angiogenesis by binding to the CXCR3 receptor 41 and a further unidentified receptor. 42 It is angiostatic in vitro and in vivo, 28 and inhibits both EC proliferation and the induction of apoptosis. 43, 44 CXCL10 and CXCR3 have been associated with vessel remodeling, and are associated with vessel regression in wound repair. 28 In support of this, CXCR3 knockout mice exhibit persistent angiogenesis during wound repair. 45 Regulation of CXCL10 expression by vascular cells is likely to be multifactorial. Major stimuli in a number of cell types, including in uterine microvascular EC, 21 are proinflammatory cytokines, including IFN-γ. Others have reported that IFN-γ is released by first trimester trophoblast, 29 and using a neutralizing antibody, we were able to demonstrate a role for IFN-γ in our study of vascular remodeling. We found enhanced CXCL10 expression in coculture spheroids versus spheroids made up of each individual cell type, indicating that interactions between EC and VSMC are important in the induction CXCL10. One explanation for this response is that invading trophoblast secret bioactive molecules that stimulate EC and VSMC to produce factors that act via paracrine or autocrine mechanisms to enhance the effects of IFN-γ. It is interesting to note that platelet-derived growth factor expression, which is significantly upregulated in the coculture system described above, has been shown to act synergistically with IFN-γ to stimulate CXCL10 expression in other cell systems. 46 In support of our in vitro findings, we have demonstrated that CXCL10 is expressed in α-smooth muscle actin positive cells in first trimester decidual sections. Interestingly, some cells expressing CXCL10 were found at some distance from the vessel lumen. We therefore investigated the role of both EVT CM and CXCL10 signaling on VSMC and found increased motility, as well as other functional markers of dedifferentiation. Recently, the migration of VSMC from the arteries has been associated with remodeling by trophoblast, 47 a process unique to remodeling in the decidua. Other mechanisms of disappearance of VSMC during artery remodeling are unknown, however, disruption and disorganization of the VSMC layer has been attributed to both apoptosis and dedifferentiation. 48 A decrease in α-smooth muscle actin and calponin expression was observed in VSMC treated with EVT CM, and a small but nonsignificant decrease with rhCXCL10, which indicates a switch to a dedifferentiated, synthetic phenotype. 39 A decrease in α-smooth muscle actin expression has been previously demonstrated during SA remodeling, and cells with low expression of α-smooth muscle actin were found at a distance from artery lumens, 49 similar to the CXCL10-positive cells demonstrated immunohistochemically in our study.
Evidence indicates that trophoblast synthesize and secretes many factors that could influence the structure of the vessels in both a positive and a negative manner, and that it is the balance between these factors and the way they interact with each other that will determine the extent of remodeling. VSMC have been demonstrated to express CXCR3, the receptor for CXCL10, 50, 51 and, indeed, we demonstrate CXCR3 expression in α-smooth muscle-expressing cells in the decidua. CXCL10 can also signal via a CXCR3-independent mechanism. 42 As increased proliferation and motility are markers of VSMC dedifferentiation, 52 autocrine expression and signaling of CXCL10 by VSMC may induce their motility. This has been demonstrated in other cell models, and so therefore may be possible in first trimester decidua. 53, 54 It is also possible that the release of factors such as CXCL10 act as chemokines to recruit interstitial trophoblasts or maternal immune cells, such as decidual natural killer cells, to the remodeling vessel, which are known to influence both EC and VSMC. 55 In conclusion, we have investigated trophoblast-induced changes in human decidual SA remodeling using a 3D spheroid culture system to model the interactions that occur between the different cell types in vivo. 24 We have described the potential of trophoblast-secreted factors, and the resulting increased CXCL10 expression to contribute to SA remodeling during pregnancy by altering the motility and differentiation status of the VSMC compartment of the vessel. Collectively, these results highlight the importance of 3D modeling in examining vascular interactions and provide new insights in to the mechanism of SA remodeling.
